eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | chronic myeloproliferative disease |
| Comorbidity | C0001815|bone marrow fibrosis |
| Sentences | 3 |
| PubMedID- 20200965 | (16) pdgf-a has been shown to play a role in the etiology of fibrosis during tissue regeneration and a wide variety of pathologic conditions, including bone marrow fibrosis in patients with myeloproliferative diseases. |
| PubMedID- 25757677 | The jak1 and jak2 inhibitor ruxolitinib has approved indications in myelofibrosis, a bcr-ab1-negative myeloproliferative neoplasm associated with progressive bone marrow fibrosis and shortened survival. |
| PubMedID- 21296418 | bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth. |
Page: 1